IκB/IKK
IKK (IκB kinase) is an enzyme complex that participates in NF-κB signaling pathway. It phosphorylates and inhibits IκB, thus leads to the activation of NF-κB. It is a target for treatment of inflammatory diseases and cancer.
Products Related to IκB/IKK(68)
- GC20007Ginsenoside CKCAS: 39262-14-1Purity: >98.00%
Ginsenoside CK, a secondary ginsenoside biotransformed from major ginsenosides, is more bioavailable and soluble than its parent ginsenosides and holds great significance.
- GC31319Amlexanox (AA673)CAS: 68302-57-8Purity: >99.50%
Amlexanox (AA673), a tricyclic amine carboxylic acid with oral activity, can effectively inhibit TANK-binding kinase 1 (TBK1) (IC 50 = 0.8μM) and inhibitor-kappaB kinase epsilon (IKK-ɛ) (IC 50 = 5.8μM)
- GC33816Ertiprotafib (PTP 112)CAS: 251303-04-5Purity: >98%
Ertiprotafib (PTP 112) is an inhibitor of PTP1B, IkB kinase β (IKK-β), and a dual PPARα and PPARβ agonist, with an IC50 of 1.6 μM for PTP1B, 400 nM for IKK-β, an EC50 of ~1 μM for PPARα/PPARβ.
- GC35474Bay 65-1942 free baseCAS: 600734-02-9Purity: >98%
Bay 65-1942 free base is an ATP-competitive and selective IKKβ inhibitor.
- GC35475Bay 65-1942 R formCAS: 758683-21-5Purity: >98%
Bay 65-1942 R form is the less active R-form of Bay 65-1942.
- GC37747TBK1/IKKε-IN-1CAS: 2058264-32-5Purity: >98%
TBK1/IKKε-IN-1 is a dual TBK1 and IKKε inhibitor extracted from patent US20160376283 A1, Compound 274 in Example 60, has IC50s of <100 nM.
- GC37748TBK1/IKKε-IN-5CAS: 1893397-65-3Purity: >99.50%
TBK1/IKKε-IN-5 (compound 1) is an orally active TBK1 and IKKε dual inhibitor, with IC50 values of 1 and 5.6 nM, respectively. TBK1/IKKε-IN-5 enhances the blockade response to PD-1 and induces immune memory in rats when combines with anti-PD-L1. TBK1/IKKε-IN-5 can be used in cancer research, especially in tumour immunity.
- GC61021Malachite green oxalateCAS: 2437-29-8Purity: >98.00%
Malachite green oxalate is a triphenylmethane dye which can be used to detect the release of phosphate in enzymatic reactions. Malachite green oxalate is also a potent and selective inhibitor of IKBKE, and inhibits its downstream targets such as IκBα, p65 and IRF3. Malachite green oxalate exhibits antitumor activity in vitro and in vivo.
| Catalog No. | Product Name | CAS No. | Purity | Structure |
|---|---|---|---|---|
| GC16658 | Vinpocetine | 42971-09-5 | >99.50% | |
PDE inhibitor | ||||
| GC17136 | MRT67307 | 1190378-57-4 | >98.50% | |
A kinase inhibitor | ||||
| GC17416 | ACHP | 406208-42-2 | >98% | |
IκB kinase inhibitor | ||||
| GC17603 | PS-1145 | 431898-65-6 | >99.50% | |
IKK inhibitor | ||||
| GC17873 | CID-2858522 | 758679-97-9 | >98% | |
A selective inhibitor of NF-κB activation | ||||
| GC18200 | BI-605906 | 960293-88-3 | >98.00% | |
BI-605906 is an inhibitor of inhibitor of kappa B kinase subunit β (IKKβ; IC50 = 380 nM). | ||||
| GC19069 | BI605906 | 960293-88-3 | - | |
BI605906 is a novel IKKβ inhibitor with an IC50 value of 380 nM when assayed at 0.1 mM ATP. | ||||
| GC20007 | Ginsenoside CK | 39262-14-1 | >98.00% | |
Ginsenoside CK, a secondary ginsenoside biotransformed from major ginsenosides, is more bioavailable and soluble than its parent ginsenosides and holds great significance. | ||||
| GC31319 | Amlexanox (AA673) | 68302-57-8 | >99.50% | |
Amlexanox (AA673), a tricyclic amine carboxylic acid with oral activity, can effectively inhibit TANK-binding kinase 1 (TBK1) (IC 50 = 0.8μM) and inhibitor-kappaB kinase epsilon (IKK-ɛ) (IC 50 = 5.8μM) | ||||
| GC32028 | BMS-066 | 914946-88-6 | >98% | |
BMS-066 is an IKKβ/Tyk2 pseudokinase inhibitor, with IC50s of 9 nM and 72 nM, respectively. | ||||
| GC33306 | IMD-0560 | 439144-66-8 | >99.50% | |
IMD-0560 is a novel IκB kinase β inhibitor. | ||||
| GC33816 | Ertiprotafib (PTP 112) | 251303-04-5 | >98% | |
Ertiprotafib (PTP 112) is an inhibitor of PTP1B, IkB kinase β (IKK-β), and a dual PPARα and PPARβ agonist, with an IC50 of 1.6 μM for PTP1B, 400 nM for IKK-β, an EC50 of ~1 μM for PPARα/PPARβ. | ||||
| GC34907 | INH14 | 200134-22-1 | >98.00% | |
INH14 is a cell permeable inhibitor of IKKα/IKKβ, with IC50s of 8.97 and 3.59 μM, respectively. | ||||
| GC35474 | Bay 65-1942 free base | 600734-02-9 | >98% | |
Bay 65-1942 free base is an ATP-competitive and selective IKKβ inhibitor. | ||||
| GC35475 | Bay 65-1942 R form | 758683-21-5 | >98% | |
Bay 65-1942 R form is the less active R-form of Bay 65-1942. | ||||
| GC35674 | Chicanine | 78919-28-5 | >98% | |
Chicanine is a lignan compound of Schisandra chinesis, inhibits LPS-induced phosphorylation of p38 MAPK, ERK 1/2 and IκB-α, with anti-inflammatory activity. | ||||
| GC37747 | TBK1/IKKε-IN-1 | 2058264-32-5 | >98% | |
TBK1/IKKε-IN-1 is a dual TBK1 and IKKε inhibitor extracted from patent US20160376283 A1, Compound 274 in Example 60, has IC50s of <100 nM. | ||||
| GC37748 | TBK1/IKKε-IN-5 | 1893397-65-3 | >99.50% | |
TBK1/IKKε-IN-5 (compound 1) is an orally active TBK1 and IKKε dual inhibitor, with IC50 values of 1 and 5.6 nM, respectively. TBK1/IKKε-IN-5 enhances the blockade response to PD-1 and induces immune memory in rats when combines with anti-PD-L1. TBK1/IKKε-IN-5 can be used in cancer research, especially in tumour immunity. | ||||
| GC43786 | GS-143 | 916232-21-8 | >98.00% | |
GS-143 is an inhibitor of IκBα ubiquitylation. | ||||
| GC50093 | MRT 68601 hydrochloride | 1962928-25-1 | >98% | |
Potent TBK inhibitor | ||||
| GC60624 | BAY-985 | 2409479-29-2 | >99.50% | |
A dual inhibitor of TBK1 and IKKε | ||||
| GC61021 | Malachite green oxalate | 2437-29-8 | >98.00% | |
Malachite green oxalate is a triphenylmethane dye which can be used to detect the release of phosphate in enzymatic reactions. Malachite green oxalate is also a potent and selective inhibitor of IKBKE, and inhibits its downstream targets such as IκBα, p65 and IRF3. Malachite green oxalate exhibits antitumor activity in vitro and in vivo. | ||||
| GC62161 | HOIPIN-1 | - | >97.00% | |
HOIPIN-1 (JTP-0819958) is a selective linear ubiquitin chain assembly complex (LUBAC) inhibitor with an IC50 of 2.8 μM. HOIPIN-1 suppress LUBAC-mediated NF-kB activation in vitro. | ||||
| GC63007 | HPN-01 | 928655-63-4 | >98.00% | |
HPN-01 is a potent and selective IKK inhibitor, with pIC50 values of 6.4, 7.0 and <4.8 for IKK-α, IKK-β and IKK-ε, respectively. | ||||
